Lecanemab Extension Study for AD Offers Mixed Results
The lecanemab open-label extension trial for AD showed no new safety signals, but the placebo roll-over group failed to show the gains seen in the experimental arm.
Source: medscape.com
Michael Irizarry News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Michael Irizarry. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Michael Irizarry Today - Breaking & Trending Today
Cool in School: 24 students inducted into Olean High National Honor Society
OLEAN — The Olean High School chapter of the National Honor Society welcomed its newest members in a ceremony Jan. 5 at the Pulaski Club.
Source: oleantimesherald.com
Subcutaneous Alzheimer's Drug May Be on the Horizon
Investigational version of lecanemab shows promise, but questions about safety persist
Source: medpagetoday.com
Injected version of Eisai/Biogen Alzheimer's drug works as well as IV Leqembi
An injected version of Eisai and Biogen's Alzheimer's drug Leqembi works as well as the current intravenous version at removing toxic brain plaques, according to an analysis presented by Eisai...
Source: marketscreener.com
Injected version of Eisai/Biogen Alzheimer's drug effective | The Asahi Shimbun: Breaking News, Japan News and Analysis
BOSTON--An injected version of Eisai and Biogen's Alzheimer's drug Leqembi works as well as the current intravenous administration at removing toxic brain plaques, but rates of serious side effects were higher, according to an analysis presented by Eisai on Wednesday.
Source: asahi.com